Completed NA INTERVENTIONAL 1-arm NCT04988204

Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease

Pilot Study: Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions Nonalcoholic Fatty Liver Disease

Interventions Diabetes Prevention Program

Updated 3 times since 2021 Last updated: Jul 28, 2021 Started: Oct 3, 2018 Primary completion: Oct 31, 2019 Completion: Oct 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04988204, this NA trial focuses on Nonalcoholic Fatty Liver Disease and remains completed. Sponsored by Icahn School of Medicine at Mount Sinai, it has been updated 3 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2021 — Jul 2024 [monthly]

Completed NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai

Data source: Icahn School of Medicine at Mount Sinai

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States